FIRSTS IN PATIENT CARE
Elin Lewis, a 12-year-old from Greenwood, Indiana, made history as the first patient in the state to receive a groundbreaking gene therapy for transfusion-dependent beta-thalassemia, a severe inherited blood disorder that affects approximately 1,500 people in the United States. Performed at Riley Children’s Health, the procedure represents a revolutionary shift from lifelong disease management to a potential cure. READ about the efforts that made this possible, as Riley Children’s joins the small number of health systems nationwide able to deliver the complex treatment. PATHFINDERS >
“Years of progress in gene addition and collaboration between researchers and clinicians made this moment possible. This is such a big step for Riley to be offering these next-generation therapies. Elin’s success paves the way for other patients at Riley and across Indiana.”
Jonathan G. Bardahl, DO Pediatric stem cell transplant specialist Assistant Professor of Clinical Pediatrics, IU School of Medicine > Connect with Dr. Bardahl on Doximity.
With access to the latest clinical trials and therapies, Riley specialists treat the full spectrum of pediatric cancers and blood diseases, including aggressive conditions that are no longer responsive to conventional therapy. > Learn more about our program.
HEMATOLOGY, ONCOLOGY & STEM CELL TRANSPLANT AT RILEY CHILDREN’S
Made with FlippingBook flipbook maker